845546-23-8 Usage
General Description
The chemical 1-(3-fluorobenzyl)-5-oxopyrrolidine-3-carboxylic acid, also known as SALTDATA: FREE, is a compound with a molecular structure that includes a fluorobenzyl group attached to a pyrrolidine ring with a carboxylic acid functional group. 1-(3-fluorobenzyl)-5-oxopyrrolidine-3-carboxylic acid(SALTDATA: FREE) may have potential applications in pharmaceuticals or as a building block for organic synthesis. The presence of the fluorobenzyl group could make this compound useful in drug design for targeting specific receptors or enzymes. Additionally, the carboxylic acid functional group allows for potential conjugation with other molecules and may contribute to the compound's solubility and stability. Further research and testing would be needed to determine the full range of potential uses and properties of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 845546-23-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,5,4 and 6 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 845546-23:
(8*8)+(7*4)+(6*5)+(5*5)+(4*4)+(3*6)+(2*2)+(1*3)=188
188 % 10 = 8
So 845546-23-8 is a valid CAS Registry Number.
845546-23-8Relevant articles and documents
CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT
-
Page/Page column 30, (2008/06/13)
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.
